Zevra Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

DB:1GDA Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
11 Oct 24	Buy€3,615	Corey Watton	Individual	500	€7.23
17 Jul 24	Buy€12,382	R. Clifton	Individual	2,000	€6.19
16 Jul 24	Buy€62,545	Thomas Anderson	Individual	10,000	€6.25
12 Jul 24	Buy€53,792	John Bode	Individual	10,000	€5.38

Insider Trading Volume

Insider Buying: 1GDA insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 1GDA?
Owner Type	Number of Shares	Ownership Percentage
Private Companies	20,858	0.0391%
Individual Insiders	3,298,323	6.18%
Hedge Funds	6,972,674	13.1%
General Public	20,821,518	39%
Institutions	22,262,559	41.7%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 28.7%.

Top Shareholders

Top 25 shareholders own 54.76% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
7.59%	Woodline Partners LP	4,048,653	€33.5m	253%	0.31%
5.85%	BlackRock, Inc.	3,121,759	€25.8m	15.8%	no data
5.66%	Samuel Braun	3,021,660	€25.0m	0%	no data
5.48%	Nantahala Capital Management, LLC	2,924,021	€24.2m	20.9%	1.92%
5.16%	The Vanguard Group, Inc.	2,756,061	€22.8m	50.3%	no data
4.33%	FMR LLC	2,313,166	€19.1m	301,000%	no data
3.18%	Altium Capital Management LP	1,700,000	€14.0m	46.3%	4.7%
2.3%	683 Capital Management, LLC	1,225,000	€10.1m	53.1%	1.1%
1.96%	Geode Capital Management, LLC	1,043,864	€8.6m	14.2%	no data
1.84%	J. Goldman & Co., L.P.	984,182	€8.1m	0%	0.35%
1.45%	State Street Global Advisors, Inc.	772,825	€6.4m	7.36%	no data
1.31%	Stonepine Capital Management LLC	700,000	€5.8m	0%	2.17%
1.22%	Adage Capital Management, L.P.	649,000	€5.4m	0%	0.01%
0.98%	Vestal Point Capital, LP	525,000	€4.3m	0%	0.37%
0.94%	The Retirement Planning Company of New England, Inc.	499,505	€4.1m	8.99%	2.12%
0.78%	Stratos Wealth Partners, Ltd	418,640	€3.5m	496%	0.05%
0.72%	ExodusPoint Capital Management, LP	386,245	€3.2m	0%	0.03%
0.66%	Northern Trust Global Investments	354,720	€2.9m	20.9%	no data
0.66%	Silverarc Capital Management, LLC	350,000	€2.9m	0%	0.71%
0.58%	Mystic Asset Management, Inc.	307,447	€2.5m	3.19%	0.98%
0.57%	Janney Montgomery Scott LLC, Asset Management Arm	305,069	€2.5m	-29.5%	0.01%
0.43%	Teachers Insurance and Annuity Association-College Retirement Equities Fund	227,164	€1.9m	75.1%	no data
0.4%	Susquehanna International Group, LLP, Asset Management Arm	214,798	€1.8m	55.1%	no data
0.37%	Velan Capital Partners LP	200,000	€1.7m	0%	1.69%
0.34%	Propel Bio Management, LLC	179,874	€1.5m	0%	1.5%

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/25 02:43
End of Day Share Price	2024/12/23 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Zevra Therapeutics, Inc. is covered by 16 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Dewey Steadman	Canaccord Genuity
Sumant Satchidanand Kulkarni	Canaccord Genuity
Louise Chen	Cantor Fitzgerald & Co.